Potent Anti-R5 Human Immunodeficiency Virus Type 1 Effects of a CCR5 Antagonist, AK602/ONO4128/GW873140, in a Novel Human Peripheral Blood Mononuclear Cell Nonobese Diabetic-SCID, Interleukin-2 Receptor γ-Chain-Knocked-Out AIDS Mouse Model

類似資料

• Hepatotoxicity Observed in Clinical Trials of Aplaviroc (GW873140)
  著者:: Nichols, W. G., 等
  出版事項: (2008)
• Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro
  著者:: Maeda, Kenji, 等
  出版事項: (2004)
• The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency.
  著者:: Prochazka, M, 等
  出版事項: (1992)
• Pharmacokinetics and Short-Term Safety of 873140, a Novel CCR5 Antagonist, in Healthy Adult Subjects
  著者:: Adkison, Kimberly K., 等
  出版事項: (2005)
• Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic–scid/scid mice
  著者:: Conneally, E., 等
  出版事項: (1997)